A new study finds that perimenopausal women are at a higher risk of developing insomnia, with symptoms escalating over the transition period to menopause. The odds of having any one symptom of insomnia were 1.3 times greater for those in late stage versus early stage of perimenopause.
A new study reveals that menopause diminishes the impact of high-density lipoprotein (HDL) in preventing plaque buildup and artery hardening. The research found a positive association between increases in HDL levels and greater plaque buildup among women transitioning through menopause.
A new study demonstrates that vitamin D3 supplementation can increase muscle strength in postmenopausal women by up to 25.3% and reduce the loss of muscle mass, while also reducing the risk of falls. The trial found that vitamin D supplements provided significant protection against sarcopenia, a degenerative loss of skeletal muscle.
A new study found that local estrogens, such as vaginal tablets, may be more effective than cream in treating genitourinary symptoms of menopause. Women who took tablets were more likely to adhere to treatment guidelines and show improved results.
A new study suggests that early initiation of menopausal hormone therapy within five years of menopause onset reduces the risk of future coronary heart disease. Conversely, late initiation is associated with an increased risk of incident coronary heart disease.
A national survey reveals that nearly a third of US women taking hormones at menopause are using unapproved and untested compounded hormones. The study found four cases of endometrial cancer among these users, highlighting the risks associated with these therapies.
A new study published by Mayo Clinic reveals a significant link between recent abuse and menopause-related symptoms. Verbal and emotional abuse were found to have the most impact on women's experiences, while physical and sexual abuse also played a role in increased symptom severity.
A NAMS panel recommends behavioral approaches like cognitive-behavioral therapy and clinical hypnosis as effective in reducing hot flash symptoms. Nonhormonal prescription medications, such as SSRIs and gabapentinoids, are also recommended for their mild to moderate improvements.
The North American Menopause Society (NAMS) has honored several individuals for their outstanding contributions to menopause science, care, and communication. NAMS has awarded JoAnn E. Manson, MD, DrPH, NCMP, for her leadership in clinical trials and research on cardiovascular disease, diabetes, and cancer.
A new study demonstrates postmenopausal women's willingness to use vaginal estrogen (VE) to alleviate painful intercourse and vaginal dryness, with benefits comparable to or exceeding systemic hormone therapy. The study suggests that VE may be a viable solution for certain urogenital problems in menopausal women.
A recent study found that current smokers who experience early menopause can expect to die 2.6 years earlier than those with a later age at menopause. The study also revealed that women with late menopause were more likely to be nonsmokers and use hormone therapy.
The North American Menopause Society (NAMS) revised its recommendations to support the judicious use of systemic hormone therapy in women over 65. The organization acknowledges that hot flashes can persist into the mid-60s, posing a challenge for treatment guidelines and clinical practice.
A new study confirms that 53% of menopausal women use at least one type of CAM for symptom management, raising safety concerns due to lack of medical consultation. Healthcare providers need to be aware of CAM therapies and guide patients to coordinate safe care.
A Swedish population study found that hormone therapy combined with statins significantly lowered the risk of death from any cause and cardiovascular disease in postmenopausal women. The study compared over 40,000 women who took statins with those who used hormone therapy alone or had no treatment.
A large study of 2,000 Australian women aged 40-65 found that 42% of those between 60-65 years old experienced hot flashes, while 62% continued to experience sexual symptoms. The study highlights the need for better treatment options for these women, many of whom are not receiving adequate care.
A recent study analyzed two large surveys to gauge the use of approved and unapproved hormone therapy among US women at menopause. Women taking compounded hormones often lack understanding about the risks associated with these treatments, which are not tested in clinical trials before dispensing.
A study published in Menopause found a link between early menopause and chronic fatigue syndrome in women, with 66% of those with CFS having undergone at least one gynecologic surgery. Women with CFS reported excessive bleeding and used hormones for purposes other than contraception more frequently.
A Women's Health Initiative study found that removing ovaries lowers the risk of pelvic organ prolapse in women after menopause. Age, rather than menopause, is a stronger predictor of the condition.
A study of American women aged 45-55 found that soy helps alleviate hot flashes in those whose bodies can produce equol, a soy metabolite. Women with the most soy in their diet experienced 76% fewer hot flashes compared to those with less soy intake.
A new study found that younger postmenopausal women with normal bone density are at a very low risk of fractures. Without osteoporosis, it took an average of 11 years for just 1% to sustain a vertebral fracture and 3% to sustain a major osteoporotic fracture.
The North American Menopause Society (NAMS) has launched a free menopause mobile app, MenoPro, that uses an algorithm to help clinicians and patients make personalized treatment decisions. The app offers two modes, including one for healthcare providers and one for patients, and provides access to NAMS resources and a cardiovascular di...
The North American Menopause Society (NAMS) has published its first comprehensive set of evidence-based recommendations for the care of midlife women. The guide covers over 50 key topics, including vasomotor symptoms and osteoporosis, providing practical advice for clinicians and patients.
The new term GSM describes the complex genital, sexual, and urinary symptoms women experience after menopause. By standardizing a physical examination tool, healthcare providers can diagnose and treat these conditions more accurately and effectively.
A new study published in Menopause finds that lifelong soy consumption helps prevent atherosclerosis and improves cholesterol levels in premenopausal monkeys. After menopause, switching to a soy diet can also improve cholesterol levels, but has limited effect on plaque progression.
A recent study found that acupuncture can positively impact both the frequency and severity of hot flashes in women undergoing natural menopause. The analysis revealed that various forms of acupuncture, including traditional Chinese medicine and sham acupuncture, were effective in reducing hot flash frequency for up to three months.
A pilot study found a significant correlation between weight loss and reduced hot flashes in overweight or obese women. The study's findings suggest that behavioral weight loss may be an effective method for managing menopausal hot flashes, promoting healthy aging and overall well-being.
A nested case-control study found an association between older maternal age at birth of the last child and exceptional longevity. Women who had their last child beyond age 33 years had twice the odds for survival, with an increased risk tempered by having multiple children.
A new study published in Menopause found that calcium and vitamin D supplements can lead to high levels of calcium in the blood and urine in some older women. The risk was higher for those with lower initial calcium levels and increased age.
A recent study published in Menopause found that low doses of testosterone cream for women after menopause can bring their testosterone levels back to normal. The study tested two doses of the AndroFeme product, with the 5-mg dose being sufficient to restore premenopausal levels.
A new study found that PMS before menopause is linked to a poorer quality of life after menopause, particularly with depression, poor sleep, and memory problems.
A new study finds that women who experience early menopause at ages 40-45 are 40% more likely to develop heart failure than those who enter menopause between 50-54. Smoking also significantly increases the risk of heart failure in these women.
A new study from the Women's Health Initiative found no link between low vitamin D levels and menopause symptoms, including hot flashes, night sweats, and sleep disturbances. The study analyzed data from 530 women participating in the calcium and vitamin D WHI trial.
Taking care of grandkids one day a week may boost cognitive function, but excessive caregiving can have negative effects. A study of Australian grandmothers aged 57-68 found that social engagement and mental sharpness were linked.
A new study from the Women's Health Initiative found that calcium and vitamin D supplements can lower LDL cholesterol levels and raise HDL cholesterol in postmenopausal women. Vitamin D levels also played a significant role, with higher levels associated with improved cholesterol profiles.
A six-month pilot program called WAIPointes, funded by insurance, helped 83 women aged 35-55 achieve weight loss, lower blood pressure, and improved hot flash symptoms through lifestyle changes. The program's interactive approach and personalized support led to significant health risks reduction.
A new analysis of data from the Women's Interagency HIV Study reveals that anxiety is the biggest factor affecting thinking skills in midlife women with HIV. Mental processing speed and verbal memory were more closely linked to depression, anxiety, and hot flashes in both HIV-infected and healthy women.
A randomized, controlled trial shows that injecting anesthetic near a nerve bundle in the neck significantly reduces moderate to severe hot flashes in postmenopausal women. The treatment cut the number of hot flashes in half and reduced their intensity by 38% compared to a sham injection.
A study found that adding testosterone to hormone therapy did not significantly improve quality of life, self-esteem, or mood in women with primary ovarian insufficiency. Normalizing testosterone levels may not address underlying factors contributing to mood problems.
Two new studies published in Menopause journal show that low-dose flibanserin improves sexual function in postmenopausal women, while high-dose testosterone also yields benefits, but with cautionary notes on cardiovascular risks.
A new study found that hormone therapy has no significant impact on the quality of life for recently menopausal women without hot flashes. Women with moderate to severe hot flashes did experience improvements in sleep and other symptoms, but not overall health or sexual well-being.
A new study published in Menopause found that a specific bacterial mix may contribute to vaginal dryness and pain after menopause. The researchers suggest that personalized probiotics could prevent or treat vulvovaginal atrophy (VVA), a common cause of sexual pain, offering an alternative to traditional therapies.
The North American Menopause Society (NAMS) has published new guidance for diagnosing and treating vulvovaginal atrophy (VVA), a condition affecting up to 45% of women after menopause. The guidance emphasizes the importance of effective treatments, including simple vaginal lubricants, estrogen therapy, and nonhormonal options.
The North American Menopause Society (NAMS) has announced the recipients of its 2013 awards, honoring exceptional contributions to menopause research, practice, and education. This year's awards recognize outstanding clinicians, researchers, educators, and media professionals who have expanded knowledge about midlife women's health.
A 12-week aerobic exercise program showed no significant reduction in hot flashes among postmenopausal women. However, white women and those with initial fitness levels improved with exercise. Exercise had small positive effects on sleep quality, insomnia, and depression.
Women who survive cancer have more frequent, severe, and troubling hot flashes than other women with menopausal symptoms. However, the study also found that the cancer survivors reported better psychological and social well-being, similar levels of sexual activity and function compared to women without cancer.
A study published in Menopause found that women with HIV suffer from moderate to severe hot flashes, which significantly impact their daily functioning and overall well-being. The study also highlighted the potential risks of hot flashes on their health, HIV treatment, and ability to abstain from drugs and alcohol.
A large analysis of the Women's Health Initiative trial found that combining hormone therapy with calcium and vitamin D supplements significantly reduces the risk of hip fractures. The study suggests that women taking postmenopausal hormone therapy should consider taking these supplements to boost bone health.
A study of 1,500 women reveals that hot flashes and night sweats can occur before menopause, particularly among white women, Asian women, and those with certain dietary habits. The findings shed light on the complex factors influencing midlife symptoms and provide reassurance for women experiencing unexpected hot flashes.
A global survey found that treatment with vaginal estrogen improved sex lives for postmenopausal women, reducing pain and increasing satisfaction. The study also showed a positive impact on self-esteem and relationships.
Research confirms memory problems are a real symptom of menopause, exacerbated by hot flashes and negative emotions. Women experiencing more severe symptoms struggled with memory retention.